ProShares UltraShort NASDAQ Biotechnology
9 hedge funds and large institutions have $1.54M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$434K | |
| 2 | +$228K | |
| 3 | +$72K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$11.8K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$3.17K |
Top Sellers
| 1 | -$655K | |
| 2 | -$478K | |
| 3 | -$227K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$176K |
| 5 |
Morgan Stanley
New York
|
-$55K |